Effectiveness and Safety Results from Real World Experience for Cladribine Tablets in Management of Relapsing Multiple Sclerosis in Qatar- 30 Months Follow Up

Authors
Category Primary study
JournalMultiple Sclerosis and Related Disorders
Year 2023
This article has no abstract
Epistemonikos ID: f398b323d1afa8e9ff65bb86b4093a6fb0f9571f
First added on: Feb 18, 2025